title: Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models.
abstract: In this study, we compared, for the first time, the release of a 432 kDa prostaglandin F2a analogue drug, Latanoprost, from commercially available contact lenses using in vitro models with corneal epithelial cells. Conventional polyHEMA-based and silicone hydrogel soft contact lenses were soaked in drug solution (131 μg = ml solution in phosphate buffered saline). The drug release from the contact lens material and its diffusion through three in vitro models was studied. The three in vitro models consisted of a polyethylene terephthalate (PET) membrane without corneal epithelial cells, a PET membrane with a monolayer of human corneal epithelial cells (HCEC), and a PET membrane with stratified HCEC. In the cell-based in vitro corneal epithelium models, a zero order release was obtained with the silicone hydrogel materials (linear for the duration of the experiment) whereby, after 48 hours, between 4 to 6 μg of latanoprost (an amount well within the range of the prescribed daily dose for glaucoma patients) was released. In the absence of cells, a significantly lower amount of drug, between 0.3 to 0.5 μg, was released, (p <0:001). The difference observed in release from the hydrogel lens materials in the presence and absence of cells emphasizes the importance of using an in vitro corneal model that is more representative of the physiological conditions in the eye to more adequately characterize ophthalmic drug delivery materials. Our results demonstrate how in vitro models with corneal epithelial cells may allow better prediction of in vivo release. It also highlights the potential of drug-soaked silicone hydrogel contact lens materials for drug delivery purposes.
authors.affiliation: Systems Design Engineering, University of Waterloo, Waterloo, Ontario, Canada.
authors.forename: Saman
authors.initials: S
authors.lastname: Mohammadi
authors.affiliation: School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada; Centre for Contact Lens Research, University of Waterloo, Waterloo, Ontario, Canada.
authors.forename: Lyndon
authors.initials: L
authors.lastname: Jones
authors.affiliation: Systems Design Engineering, University of Waterloo, Waterloo, Ontario, Canada; School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada; Centre for Contact Lens Research, University of Waterloo, Waterloo, Ontario, Canada.
authors.forename: Maud
authors.initials: M
authors.lastname: Gorbet
mesh_terms: D003261:Contact Lenses; D003315:Cornea / Q000166:cytology*; D004058:Diffusion; D065546:Drug Liberation; D004847:Epithelial Cells / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D000077338:Latanoprost; D008954:Models, Biological; D011461:Prostaglandins F, Synthetic / Q000737:chemistry* / Q000378:metabolism
chemical_list: D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost